{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T13:34:31Z","timestamp":1793799271516,"version":"4.6.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:00:00Z","timestamp":1647907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Agents Cancer"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>Chlamydia pneumoniae<\/jats:italic>is an obligate intracellular pathogen and is a common cause of human respiratory diseases, including pneumonia. It has been already known to have a causal relationship with some chronic diseases such as chronic obstructive pulmonary disease, asthma, and atherosclerotic cardiovascular diseases. In this review, we aim to find out the association between<jats:italic>C. pneumoniae<\/jats:italic>infection and lung cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a systematic review on<jats:italic>C. pneumoniae<\/jats:italic>infection and the development of lung cancer, based on published articles consolidated from PubMed and Google Scholar on the topic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Out of 46 articles, 27 were selected and screened through the process. Twenty-four articles positively supported the hypothesis with one animal model, while 3 of them were negatively supportive. Several proposed mechanisms explain the pathogenesis with some knowledge gaps.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Although some studies showed an association between<jats:italic>C. pneumoniae<\/jats:italic>infection and lung cancer, whether the<jats:italic>C. pneumoniae<\/jats:italic>infection is an individual risk factor for lung cancer is still debatable. And it needs further experimental studies on both humans and animals with large observational studies to better understand the association between<jats:italic>C. pneumoniae<\/jats:italic>infection and lung cancer.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13027-022-00425-3","type":"journal-article","created":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T17:05:00Z","timestamp":1647968700000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Chlamydia pneumoniae infections and development of lung cancer: systematic review"],"prefix":"10.1186","volume":"17","author":[{"given":"Nadeesha Madushani","family":"Premachandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5051-530X","authenticated-orcid":false,"given":"J. A. A. Sampath","family":"Jayaweera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,22]]},"reference":[{"key":"425_CR1","doi-asserted-by":"crossref","unstructured":"Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR) Clinical Microbiology Reviews. American Society for Microbiology; 1995 [cited 2021 Jun 21]. p. 451\u201361. https:\/\/journals.asm.org\/journal\/cmr","DOI":"10.1128\/CMR.8.4.451"},{"key":"425_CR2","unstructured":"E. P. Is Chlamydophila pneumoniae an etiological agent of non-infectious diseases? Vol. 44, Postepy Mikrobiologii. 2005."},{"key":"425_CR3","unstructured":"Chlamydia pneumoniae Infection and Inflammatory Diseases [Internet]. [cited 2021 Jun 21]. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6345537\/"},{"key":"425_CR4","doi-asserted-by":"crossref","unstructured":"Porritt RA, Crother TR. Chlamydia pneumoniae infection and inflammatory diseases [Internet]. Vol. 7, Forum on Immunopathological Diseases and Therapeutics. Begell House Inc.; 2016 [cited 2021 Jun 21]. p. 237\u201354.","DOI":"10.1615\/ForumImmunDisTher.2017020161"},{"key":"425_CR5","doi-asserted-by":"crossref","unstructured":"Shen M, Cai L, Jiang K, Xu W, Chen Y, Xu Z. The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AX. Cancer Biomarkers. 2019;","DOI":"10.3233\/CBM-181999"},{"key":"425_CR6","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"425_CR7","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.soc.2016.02.003","volume":"25","author":"M Zheng","year":"2016","unstructured":"Zheng M. Classification and pathology of lung cancer. Surg Oncol Clin N Am. 2016;25(3):447\u201368. https:\/\/doi.org\/10.1016\/j.soc.2016.02.003.","journal-title":"Surg Oncol Clin N Am"},{"issue":"4","key":"425_CR8","first-page":"2568","volume":"17","author":"A Rizzo","year":"2015","unstructured":"Rizzo A, Carratelli CR, De Filippis A, Nazario B, Tufano MA, Buommino E. Transforming Chlamydia pneumoniae in human mesothelial cells. Int Microbiol. 2015;17(4):2568.","journal-title":"Int Microbiol"},{"issue":"1","key":"425_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1186\/s12885-020-07418-8","volume":"20","author":"X Xu","year":"2020","unstructured":"Xu X, Liu Z, Xiong W, Qiu M, Kang S, Xu Q, Cai L, He F. Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China. BMC Cancer. 2020;20(1):903. https:\/\/doi.org\/10.1186\/s12885-020-07418-8.","journal-title":"BMC Cancer"},{"issue":"6","key":"425_CR10","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1158\/1055-9965.EPI-09-1261","volume":"19","author":"AK Chaturvedi","year":"2010","unstructured":"Chaturvedi AK, Gaydos CA, Agreda P, Holden JP, Chatterjee N, Goedert JJ, et al. Chlamydia pneumoniae infection and risk for lung cancer. Cancer Epidemiol Biomark Prev. 2010;19(6):879.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"10","key":"425_CR11","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1158\/1055-9965.1624.13.10","volume":"13","author":"AJ Littman","year":"2004","unstructured":"Littman AJ, White E, Jackson LA, Thornquist MD, Gaydos CA, Goodman GE, Vaughan TL. Chlamydia pneumoniae infection and risk of lung cancer. Cancer Epidemiol Biomark Prev. 2004;13(10):1624\u201330.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"11","key":"425_CR12","doi-asserted-by":"publisher","first-page":"5785","DOI":"10.2147\/CMAR.S186217","volume":"28","author":"WM Xiong","year":"2019","unstructured":"Xiong WM, Xu QP, Xiao RD, Hu ZJ, Cai L, He F. Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China. Cancer Manag Res. 2019;28(11):5785\u201397. https:\/\/doi.org\/10.2147\/CMAR.S186217.","journal-title":"Cancer Manag Res"},{"issue":"11","key":"425_CR13","first-page":"1263","volume":"9","author":"LA Jackson","year":"2000","unstructured":"Jackson LA, Wang SP, Nazar-Stewart V, Grayston JT, Vaughan TL. Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer. Cancer Epidemiol Biomark Prev. 2000;9(11):1263\u20136.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"1","key":"425_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/(sici)1097-0215(19970220)74:1<31::aid-ijc6>3.0.co;2-1","volume":"74","author":"AL Laurila","year":"1997","unstructured":"Laurila AL, Anttila T, L\u00e4\u00e4r\u00e4 E, Bloigu A, Virtamo J, Albanes D, Leinonen M, Saikku P. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer. 1997;74(1):31\u20134. https:\/\/doi.org\/10.1002\/(sici)1097-0215(19970220)74:1%3c31::aid-ijc6%3e3.0.co;2-1.","journal-title":"Int J Cancer"},{"issue":"3","key":"425_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1759-7714.2010.00021.x","volume":"1","author":"Z Liu","year":"2010","unstructured":"Liu Z, Su M, Yu SC, Yin ZH, Zhou BS. Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China. Thorac Cancer. 2010;1(3):126\u20139. https:\/\/doi.org\/10.1111\/j.1759-7714.2010.00021.x.","journal-title":"Thorac Cancer"},{"issue":"Pt 8","key":"425_CR16","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1099\/jmm.0.04845-0","volume":"52","author":"B Kocazeybek","year":"2003","unstructured":"Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: a case-control study. J Med Microbiol. 2003;52(Pt 8):721\u20136. https:\/\/doi.org\/10.1099\/jmm.0.04845-0.","journal-title":"J Med Microbiol"},{"issue":"9","key":"425_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1034\/j.1600-0463.2001.d01-177.x","volume":"109","author":"H Koyi","year":"2001","unstructured":"Koyi H, Brand\u00e9n E, Gnarpe J, Gnarpe H, Steen B. An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study. APIS. 2001;109(9):572\u201380. https:\/\/doi.org\/10.1034\/j.1600-0463.2001.d01-177.x.","journal-title":"APIS"},{"issue":"2","key":"425_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1177\/039463200802100221","volume":"21","author":"R Sessa","year":"2008","unstructured":"Sessa R, Santino I, Di Pietro M, Schiavoni G, Ripa C, Galdiero M, Iannone M, Izzo L, Mingazzini PI, Bolognese A, Del Piano M. No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction. Int J Immunopathol Pharmacol. 2008;21(2):415\u201320. https:\/\/doi.org\/10.1177\/039463200802100221.","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"425_CR19","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1002\/ijc.23814","volume":"123","author":"JS Smith","year":"2008","unstructured":"Smith JS, Kumlin U, Nyberg F, Fortes C, Zaridze D, Ahrens W, Bruske-Hohlfeld I, Constantinescu V, Ting J, Benhamou S, Simonato L, Boman J, Gaborieau V, Boffetta P. Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer. Int J Cancer. 2008;123(10):2469\u201371. https:\/\/doi.org\/10.1002\/ijc.23814.","journal-title":"Int J Cancer"},{"issue":"3","key":"425_CR20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1002\/ijc.20745","volume":"114","author":"WP Koh","year":"2005","unstructured":"Koh WP, Chow VT, Phoon MC, Ramachandran N, Seow A. Lack of association between chronic Chlamydophila pneumoniae infection and lung cancer among nonsmoking Chinese women in Singapore. Int J Cancer. 2005;114(3):502\u20134. https:\/\/doi.org\/10.1002\/ijc.20745.","journal-title":"Int J Cancer"},{"key":"425_CR21","unstructured":"Laurila AL, Von Hertzen L, Saikku P. Chlamydia pneumoniae and chronic lung diseases. Scand J Infect Dis. Supplement. 1997."},{"issue":"5","key":"425_CR22","doi-asserted-by":"publisher","first-page":"7854","DOI":"10.1016\/j.ejca.2010.11.003","volume":"47","author":"P Zhan","year":"2011","unstructured":"Zhan P, Suo LJ, Qian Q, Shen XK, Qiu LX, Yu LK, et al. Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis. Eur J Cancer. 2011;47(5):7854.","journal-title":"Eur J Cancer"},{"issue":"4","key":"425_CR23","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1158\/1055-9965.EPI-04-0599","volume":"14","author":"AJ Littman","year":"2005","unstructured":"Littman AJ, Jackson LA, Vaughan TL. Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomark Prev. 2005;14(4):773\u20138. https:\/\/doi.org\/10.1158\/1055-9965.EPI-04-0599.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"6","key":"425_CR24","doi-asserted-by":"publisher","first-page":"2819","DOI":"10.7314\/apjcp.2012.13.6.2819","volume":"13","author":"DJ Chu","year":"2012","unstructured":"Chu DJ, Guo SG, Pan CF, Wang J, Du Y, Lu XF, Yu ZY. An experimental model for induction of lung cancer in rats by Chlamydia pneumoniae. Asian Pac J Cancer Prev. 2012;13(6):2819\u201322. https:\/\/doi.org\/10.7314\/apjcp.2012.13.6.2819.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"8","key":"425_CR25","first-page":"5845","volume":"8","author":"C Wang","year":"2019","unstructured":"Wang C, Zhang N, Gao L. Association between Chlamydia pneumoniae infection and lung cancer: a meta-analysis. Transl Cancer Res. 2019;8(8):5845.","journal-title":"Transl Cancer Res"},{"key":"425_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s10096-012-1778-4","volume":"32","author":"MH Rozenbaum","year":"2013","unstructured":"Rozenbaum MH, Pechlivanoglou P, van der Werf TS, Lo-Ten-Foe JR, Postma MJ, Hak E. The role of Streptococcus pneumoniae in community-acquired pneumonia among adults in Europe: a meta-analysis. Eur J Clin Microbiol Infect Dis. 2013;32:305\u201316. https:\/\/doi.org\/10.1007\/s10096-012-1778-4.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"425_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/S0140-6736(10)61459-6","volume":"377","author":"O Ruuskanen","year":"2011","unstructured":"Ruuskanen O, Lahti E, Jennings LC, Murdoch DR. Viral pneumonia. Lancet. 2011;377:1264\u201375. https:\/\/doi.org\/10.1016\/S0140-6736(10)61459-6.","journal-title":"Lancet"},{"key":"425_CR28","doi-asserted-by":"publisher","unstructured":"Dillon C, Torres A, Niederman M, van der EM, Chalmers J, Welte T, Blasi F. Community-acquired pneumonia related to intracellular pathogens. Intensive Care Med. 2016. https:\/\/doi.org\/10.1007\/s00134-016-4394-4.","DOI":"10.1007\/s00134-016-4394-4"},{"key":"425_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 2","key":"425_CR30","doi-asserted-by":"publisher","first-page":"e112","DOI":"10.4103\/0019-509X.172506","volume":"52","author":"X Hua-Feng","year":"2015","unstructured":"Hua-Feng X, Yue-Ming W, Hong L, Junyi D. A meta-analysis of the association between Chlamydia pneumoniae infection and lung cancer risk. Indian J Cancer. 2015;52(Suppl 2):e112\u20135. https:\/\/doi.org\/10.4103\/0019-509X.172506.","journal-title":"Indian J Cancer"},{"issue":"4","key":"425_CR31","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/ijc.11353","volume":"107","author":"T Anttila","year":"2003","unstructured":"Anttila T, Koskela P, Leinonen M, Laukkanen P, Hakulinen T, Lehtinen M, Pukkala E, Paavonen J, Saikku P. Chlamydia pneumoniae infection and the risk of female early-onset lung cancer. Int J Cancer. 2003;107(4):681\u20132. https:\/\/doi.org\/10.1002\/ijc.11353.","journal-title":"Int J Cancer"}],"container-title":["Infectious Agents and Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13027-022-00425-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13027-022-00425-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T19:43:20Z","timestamp":1675021400000},"score":1,"resource":{"primary":{"URL":"https:\/\/infectagentscancer.biomedcentral.com\/articles\/10.1186\/s13027-022-00425-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,22]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["425"],"URL":"https:\/\/doi.org\/10.1186\/s13027-022-00425-3","relation":{},"ISSN":["1750-9378"],"issn-type":[{"value":"1750-9378","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,22]]},"assertion":[{"value":"29 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}